Latest Blog Posts
Search
Sort Results
Filter by Programming
Filter by Specific Population
Filter by Topic
- Organ and body health (57)
- Infections and cancers (22)
- Disease progression (17)
- Emotional health (16)
- Reproductive and maternal health (15)
- Prevention interventions (13)
- Testing and diagnosis (12)
- Social determinants of health (7)
- Harm reduction and substance use (5)
- Transmission and risk (5)
- Healthy living (4)
- Government and community strategies (2)
- Monitoring tests (2)
- Legal issues and human rights (1)
Filter by Infection
Search results
Current filters: Treatment
428 search results
- Some issues to consider with Dovato (dolutegravir + 3TC)
-
From TreatmentUpdate 233
2019, CATIE
Research summary - Webpage - Switching to Dovato (dolutegravir + 3TC) from a TAF-based regimen
-
From TreatmentUpdate 233
2019, CATIE
Research summary - Webpage - Dovato (dolutegravir + 3TC) in initial HIV treatment
-
From TreatmentUpdate 233
2019, CATIE
Research summary - Webpage - Biktarvy begins to get listed on provincial drug formularies
-
From TreatmentUpdate 233
2019, CATIE
Research summary - Webpage - FDA—Rare cases of liver injury with some hepatitis C treatments
-
2019, CATIE
Research summary - Webpage - Dovato approved in Canada for HIV treatment
-
2019, CATIE
Research summary - Webpage - Will gene therapy for HIV cause financial toxicity?
-
From TreatmentUpdate 232
2019, CATIE
Research summary - Webpage - Gene therapy—CRISPR starts to move forward against HIV
-
From TreatmentUpdate 232
2019, CATIE
Research summary - Webpage - B.C. study finds that providing ART and methadone in the same facility helps adherence
-
2019, CATIE
Research summary - Webpage - Update of recommendations on first- and second-line antiretroviral regimens
-
2019, World Health Organization (WHO)
Guideline or manual - PDF
More info
